Replies to post #185053 on Biotech Values

[zipjet]

the market thinks the overall size of the HCV market has decreased.

DD:

Just to be clear: The above is Rocky3’s thesis, not mine.

IF by "the HCV market" we are talking about HCV drug revenues, THEN there no question that it has decreased. ABBV undercutting on price and further cutting a deal to discount that price cuts the revenue. Any competition on price by GILD, which is to be expected also cuts the revenue.

ij